Thanks to Sector posting on the other thread regarding the companies' ramp up plan ( Pre Novartis ), they were targeting 10,000 COVID doses delivered within the first 6 months using existing methods.
A minimum rate of 20,000 doses per year minimum ( remember this includes the delay to actually achieve the ramp up, and I would expect post the ramp up 6 month period, the available doses would be higher........double if ramp up is linear).
20,000 doses, 10% Royalty would be $14 AUD, excluding all milestones.
$90 a share on COVID ARDS Authorization ?, page-49
-
- There are more pages in this discussion • 212 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |